MADRIGAL PHARMACEUTICALS, INC. (MDGL) Operating cash flow 2016–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$189.6MFY2025 · since FY2016: -$17.6M → -$189.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$189.6M | +58.4% |
| FY2024 | -$455.6M | -40.5% |
| FY2023 | -$324.2M | -44.2% |
| FY2022 | -$224.9M | -22.3% |
| FY2021 | -$183.9M | -16.7% |
| FY2020 | -$157.6M | -278.5% |
| FY2019 | -$41.6M | -63.2% |
| FY2018 | -$25.5M | -14.3% |
| FY2017 | -$22.3M | -26.7% |
| FY2016 | -$17.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice